A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients

Clinical trial NCT01753167 · COMPLETED

Trial details

NCT number: NCT01753167
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2012-12-14
Primary completion: 2014-10-15
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.